Valeric Acid

Valeric Acid

SCHEMBL148997

CCCCC(=O)O.COCCCN(C)C

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
AKR1B1 P15121 1/20 0.47
GPR84 Q9NQS5 7/20 0.45
PPARG P37231 7/20 0.45
PPARD Q03181 7/20 0.45
PPARA Q07869 7/20 0.45
HDAC11 Q96DB2 5/20 0.45
TSHR P16473 4/20 0.45
PTPN1 P18031 3/20 0.45
TLR2 O60603 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
FABP4 P15090 2/20 0.45
KMT2A Q03164 2/20 0.45
SLC22A6 Q4U2R8 1/20 0.45
SLC22A8 Q8TCC7 1/20 0.45
MEN1 O00255 1/20 0.45
ESR1 P03372 1/20 0.45
ALOX15 P16050 1/20 0.45
PDE4A P27815 1/20 0.45
PDE3A Q14432 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyric Acid SCHEMBL145707 0.91 ALDH1A1 (0.52) ALDH1A1AKR1B1GPR84TSHRSLC22A6
Propionic Acid SCHEMBL145398 0.85 ALDH1A1 (0.47) ALDH1A1ESR1DNM1KDM4AKDM4C
Octanoic Acid SCHEMBL5031491 0.84 DNM1 (0.60) ALDH1A1AKR1B1GPR84PPARGPPARD
Valeric Acid SCHEMBL3416629 0.81 GPR84 (0.64) ALDH1A1AKR1B1GPR84PPARGPPARD
Valeric Acid SCHEMBL3416082 0.81 GPR84 (0.64) ALDH1A1AKR1B1GPR84PPARGPPARD
Valeric Acid SCHEMBL6264153 0.81 GPR84 (0.64) ALDH1A1AKR1B1GPR84PPARGPPARD
Valeric Acid SCHEMBL3408013 0.81 GPR84 (0.64) ALDH1A1AKR1B1GPR84PPARGPPARD
Valeric Acid SCHEMBL3414212 0.81 AKR1B1 (0.58) ALDH1A1AKR1B1GPR84PPARGPPARD
Hexanoate SCHEMBL3408078 0.79 GPR84 (0.68) ALDH1A1AKR1B1GPR84PPARGPPARD
Hexanoate SCHEMBL3410840 0.79 AKR1B1 (0.70) ALDH1A1AKR1B1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120058057-A1 Anti-dandruff Agents MERCK PATENT GMBH (DE) 2012-03-08 US claimed
WO-2010136104-A2 ANTI-DANDRUFF AGENTS MERCK PATENT GMBH (DE) 2010-12-02 WO claimed
US-20120058057-A1 Anti-dandruff Agents MERCK PATENT GMBH (DE) 2012-03-08 US disclosed
WO-2010136104-A2 ANTI-DANDRUFF AGENTS MERCK PATENT GMBH (DE) 2010-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120058057-A1 Anti-dandruff Agents POLR1C, ETF1, PIK3C3 ALDH1A1 272/4885AKR1B1 1159/4885GPR84 2554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.